We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+53.18%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$4.46B
AUM Growth
+$1.51B
Cap. Flow
+$324M
Cap. Flow %
7.28%
Top 10 Hldgs %
35.21%
Holding
208
New
28
Increased
93
Reduced
71
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 38.6%
2 Healthcare 16.36%
3 Industrials 13.09%
4 Consumer Discretionary 9.99%
5 Communication Services 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOSE icon
126
Eos Energy Enterprises
EOSE
$1.52B
$5.44M 0.12%
+261,041
New +$3.37M
PPLI
127
People Inc
PPLI
$3.04B
$5.36M 0.12%
51,850
-12,897
-20% -$988K
AKTS
128
DELISTED
Akoustis Technologies Inc
AKTS
$5.32M 0.12%
434,679
+188,776
+77% +$1.66M
LAD icon
129
Lithia Motors
LAD
$8.41B
$5.31M 0.12%
+18,131
New +$4.96M
NMRK icon
130
Newmark Group
NMRK
$2.61B
$5.15M 0.12%
706,631
+446,018
+171% +$2.76M
RGEN icon
131
Repligen
RGEN
$9.4B
$5.11M 0.11%
26,681
-103,269
-79% -$18.8M
KIDS icon
132
OrthoPediatrics
KIDS
$633M
$5.06M 0.11%
122,714
-8,819
-7% -$404K
GAN
133
DELISTED
GAN Ltd
GAN
$4.97M 0.11%
245,139
-596,361
-71% -$9.99M
HCAT icon
134
Health Catalyst
HCAT
$132M
$4.8M 0.11%
110,204
+24,325
+28% +$897K
TTGT icon
135
TechTarget
TTGT
$276M
$4.79M 0.11%
81,098
-12,943
-14% -$669K
TTEK icon
136
Tetra Tech
TTEK
$9.1B
$4.66M 0.1%
+201,105
New +$4.53M
AERI
137
DELISTED
Aerie Pharmaceuticals
AERI
$4.51M 0.1%
333,763
+232,514
+230% +$2.81M
WNS
138
DELISTED
WNS Holdings
WNS
$4.49M 0.1%
62,256
+1,149
+2% +$77K
BLDP
139
Ballard Power Systems
BLDP
$784M
$4.31M 0.1%
184,243
+51,982
+39% +$957K
KRRO icon
140
Korro Bio
KRRO
$198M
$4.3M 0.1%
2,441
+86
+4% +$114K
ABMD
141
DELISTED
Abiomed Inc
ABMD
$4.23M 0.1%
+13,052
New +$3.61M
AUTL
142
Autolus Therapeutics
AUTL
$593M
$4.16M 0.09%
465,795
-128,072
-22% -$1.37M
CYBR
143
DELISTED
CyberArk
CYBR
$4.13M 0.09%
25,549
-1,626
-6% -$189K
SGMO
144
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4.03M 0.09%
257,976
+144,588
+128% +$1.69M
ECPG icon
145
Encore Capital Group
ECPG
$1.97B
$3.81M 0.09%
97,936
+6,965
+8% +$253K
RDWR icon
146
Radware
RDWR
$1.2B
$3.63M 0.08%
130,789
+3,074
+2% +$76.8K
FLEX icon
147
Flex
FLEX
$45.3B
$3.61M 0.08%
+266,300
New +$3.08M
PRTK
148
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3.61M 0.08%
576,122
-112,124
-16% -$660K
PTC icon
149
PTC
PTC
$16.4B
$3.58M 0.08%
29,921
-821
-3% -$81.7K
QLYS icon
150
Qualys
QLYS
$6.45B
$3.57M 0.08%
29,258
+598
+2% +$59.2K

Similar funds

Granahan Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Granahan Investment Management held 208 positions worth $4.46B, up 51% from $2.95B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Granahan Investment Management deployed $324M of net new capital in Q4 2020, opening 28 new positions and adding to 93 existing holdings. Its largest new stake was dMY Technology Group, Inc. II: 3,436,892 shares worth $60.5M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Magnite, an estimated $50.1M trimmed.

  • Granahan Investment Management's largest Q4 2020 buy was dMY Technology Group, Inc. II: 3,436,892 shares worth $60.5M.
  • Granahan Investment Management added most to Workiva in Q4 2020, an estimated $52.1M increase.
  • Granahan Investment Management's biggest Q4 2020 reduction was Magnite, cutting an estimated $50.1M.
  • Granahan Investment Management fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $33.7M.
  • Granahan Investment Management's ten largest holdings make up 35% of its $4.46B portfolio in Q4 2020.
  • Granahan Investment Management opened 28 new positions and closed 16 in Q4 2020.
  • Granahan Investment Management's portfolio value rose 51% quarter-over-quarter to $4.46B.

Based on Granahan Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.